Compounds > topotecan
Page last updated: 2024-08-24

topotecan and Carcinoma, Papillary

topotecan has been researched along with Carcinoma, Papillary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baykal, C; Baykal, Y; Ozer, S; Tulunay, G1
Collado, MV; García Villanueva, A; Pérez de Oteyza, J; Rojo, R; Ruiz-Tovar, J1

Other Studies

2 other study(ies) available for topotecan and Carcinoma, Papillary

ArticleYear
Topotecan induced nail pigmentation.
    The Journal of dermatology, 2004, Volume: 31, Issue:11

    Topics: Aged; Antineoplastic Agents; Carcinoma, Papillary; Female; Follow-Up Studies; Humans; Hyperpigmentation; Nail Diseases; Ovarian Neoplasms; Topotecan

2004
Papillary serous carcinoma of peritoneum: presentation of 2 cases.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:10

    Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Female; Follow-Up Studies; Humans; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Postoperative Care; Radiography, Abdominal; Time Factors; Tomography, X-Ray Computed; Topotecan; Treatment Outcome

2006